COVID-19 Acute Respiratory Distress Syndrome
Infectious Disease
Prevalence
30.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target COVID-19 Acute Respiratory Distress Syndrome?
There are 1 clinical trial targeting COVID-19 Acute Respiratory Distress Syndrome tracked by BioSniper.
What is the prevalence of COVID-19 Acute Respiratory Distress Syndrome?
The estimated prevalence of COVID-19 Acute Respiratory Distress Syndrome is approximately 30.0 per 100,000 population.
Deep-dive into COVID-19 Acute Respiratory Distress Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis